A detailed history of Foundry Partners, LLC transactions in Organon & Co. stock. As of the latest transaction made, Foundry Partners, LLC holds 399,494 shares of OGN stock, worth $5.88 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
399,494
Holding current value
$5.88 Million
% of portfolio
0.39%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$18.65 - $23.03 $7.45 Million - $9.2 Million
399,494 New
399,494 $7.64 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.75B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Foundry Partners, LLC Portfolio

Follow Foundry Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foundry Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foundry Partners, LLC with notifications on news.